Stock Price
3.41
Daily Change
0.02 0.55%
Monthly
-14.57%
Yearly
78.47%
Q2 Forecast
3.30

EDAP TMS reported EUR29.84M in Cash and Equivalent for its fiscal quarter ending in December of 2024.





Cash And Equivalent Change Date
AngioDynamics USD 41.64M 14.26M Sep/2025
Boston Scientific USD 1.96B 690M Dec/2025
EDAP TMS EUR 29.84M 4.35M Dec/2024
Henry Schein USD 136M 9M Sep/2025
Medtronic USD 1.15B 135M Dec/2025
Plus Therapeutics USD 4.26M 9.03M Dec/2025
Veracyte USD 362.58M 47M Dec/2025